References
- Allam MF, Del Castillo AS, Diaz-Molina C, Navajas RF. Invasive pulmonary aspergillosis: identification of risk factors. Scand J Infect Dis 2002;34:819-22. https://doi.org/10.1080/0036554021000026954
- Shakoor MT, Ayub S, Ayub Z, Mahmood F. Fulminant invasive aspergillosis of the mediastinum in an immunocompetent host: a case report. J Med Case Rep 2012;6:311. https://doi.org/10.1186/1752-1947-6-311
- Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408-15. https://doi.org/10.1056/NEJMoa020191
- Patterson TF, Kirkpatrick WR, White M, Hiemenz JW, Wingard JR, Dupont B, et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore) 2000;79:250-60. https://doi.org/10.1097/00005792-200007000-00006
- Mennink-Kersten MA, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004;4:349-57. https://doi.org/10.1016/S1473-3099(04)01045-X
- Song KH, Lee S, Jang HC, Jeon JH, Park WB, Park KU, et al. Diagnostic usefulness of galactomannan assay for invasive aspergillosis. Infect Chemother 2009;41:82-9. https://doi.org/10.3947/ic.2009.41.2.82
- Aquino VR, Goldani LZ, Pasqualotto AC. Update on the contribution of galactomannan for the diagnosis of invasive aspergillosis. Mycopathologia 2007;163:191-202. https://doi.org/10.1007/s11046-007-9010-2
- Balloy V, Huerre M, Latge JP, Chignard M. Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis. Infect Immun 2005;73:494-503. https://doi.org/10.1128/IAI.73.1.494-503.2005
- Pasqualotto AC, Denning DW. Post-operative aspergillosis. Clin Microbiol Infect 2006;12:1060-76. https://doi.org/10.1111/j.1469-0691.2006.01512.x
- Woods GL, Wood RP, Shaw BW Jr. Aspergillus endocarditis in patients without prior cardiovascular surgery: report of a case in a liver transplant recipient and review. Rev Infect Dis 1989; 11:263-72. https://doi.org/10.1093/clinids/11.2.263
- Mullen P, Jude C, Borkon M, Porterfield J, Walsh TJ. Aspergillus mural endocarditis. Clinical and echocardiographic diagnosis. Chest 1986;90:451-2. https://doi.org/10.1378/chest.90.3.451
- Hori A, Kami M, Kishi Y, Machida U, Matsumura T, Kashima T. Clinical significance of extra-pulmonary involvement of invasive aspergillosis: a retrospective autopsy-based study of 107 patients. J Hosp Infect 2002;50:175-82. https://doi.org/10.1053/jhin.2001.1170
Cited by
- Invasive Aspergillosis Involving the Mediastinum in an Immunocompetent Patient: A Case Report vol.9, pp.8, 2014, https://doi.org/10.7759/cureus.1605
- Fulminant Cryptococcus neoformans infection with fatal pericardial tamponade in a patient with chronic myelomonocytic leukaemia who was treated with ruxolitinib: Case report and review of fungal peric vol.61, pp.4, 2014, https://doi.org/10.1111/myc.12735
- Invasive mediastinal aspergillosis presenting as superior vena cava syndrome in an immunocompetent patient vol.2018, pp.sep_211, 2014, https://doi.org/10.1136/bcr-2018-225614